Health experts are warning that rapid weight loss from popular injection drugs like Ozempic and Wegovy may come with a hidden risk: significant muscle loss. While these medications, known as GLP-1 receptor agonists, have been hailed for their effectiveness in shedding pounds, concerns are growing that they could lead to muscle wasting, particularly when used without proper dietary support or exercise.
The drugs, which include semaglutide and liraglutide, work by suppressing appetite and slowing digestion, leading to reduced calorie intake. However, rapid weight loss often results in a loss of both fat and muscle. Muscle loss can have serious health consequences, including a slower metabolism, increased risk of falls and fractures, and long-term metabolic issues.
UK surgeons have also warned that the rise in use of these jabs could lead to an increase in overseas trips for excess skin removal surgeries. As people lose weight quickly, loose skin can become a problem, requiring surgical intervention that is not always covered by public health systems.
Some users have reported side-effects such as nausea, vomiting, and fatigue, while others have found the drugs reset their relationship with food. But experts stress that these medications should be used as part of a comprehensive weight management plan that includes diet, exercise, and medical supervision to minimize risks like muscle loss.
The long-term effects of these drugs are still being studied, and there is concern that weight may be regained once treatment stops. Health professionals advise that anyone considering these injections should discuss potential risks, including muscle loss, with their doctor.
